Underuse of Parkinson's device questioned in Germany
This article was originally published in Clinica
Executive Summary
Germany lags behind the majority of western European countries in providing patients suffering from Parkinson's disease with pioneering therapy in the form of a deep brain stimulation device (see Clinica No 1002, p 23), claims the European Parkinson's Disease Association (EPDA). Medtronic's Activa Parkinson's Control Therapy device could be used to treat an estimated 20% of sufferers, it says, but it is used on only 5.2% of patients in Germany.